Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurhanewicz, J.
Right arrow Articles by Nelson, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurhanewicz, J.
Right arrow Articles by Nelson, S. J.

Radiology, Vol 198, 795-805, Copyright © 1996 by Radiological Society of North America

ARTICLES

Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

J Kurhanewicz, DB Vigneron, H Hricak, P Narayan, P Carroll and SJ Nelson
Department of Radiology, University of California, San Francisco 94143- 0738, USA.

PURPOSE: To evaluate if three-dimensional hydrogen-1 magnetic resonance spectroscopic imaging (3D MRSI) when combined with a clinical MR imaging examination could discriminate prostatic adenocarcinoma from normal prostatic zonal anatomy and benign prostatic hyperplasia (BPH) on the basis of observable metabolite levels. MATERIALS AND METHODS: Combined phased-array, endorectal MR imaging and 3D MRSI was performed in nine young healthy volunteers, five patients with BPH, and 85 patients with prostate cancer and BPH. Volume MR imaging and 3D MRSI data were analytically corrected for the reception profile of the endorectal and pelvic phased-array coils, aligned with the MR imaging data, and compared with postoperative pathologic histology findings. RESULTS: Statistically significant variations in metabolite levels with prostatic zonal anatomy, age, and pathologic condition were detected with a 3D MRSI examination added to a clinical MR imaging examination. Significantly higher choline levels and significantly lower citrate levels were observed in regions of cancer compared with BPH and normal peripheral zone tissues. The ratio (choline + creatine/citrate) in regions of cancer (2.1 +/- 1.3 [standard deviation]) had no overlap with normal peripheral zone values and minimal overlap with BPH values (0.61 +/- 0.21). An estimate of the spatial extent of prostate cancer was determined by generating metabolite images in which this metabolite ratio significantly exceeded normal peripheral zone values in multiple contiguous sections. CONCLUSION: These results suggest that a 3D MRSI examination added to a clinical MR imaging examination may help define the presence and spatial extent of prostate cancer.


This article has been cited by other articles:


Home page
 Br. J. Radiol.Home page
N VAN AS, E CHARLES-EDWARDS, A JACKSON, S JHAVAR, S REINSBERG, N DESOUZA, D DEARNALEY, M BAILEY, A THOMPSON, T CHRISTMAS, et al.
Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens
Br. J. Radiol., June 1, 2008; 81(966): 456 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. P.F. Gade, J. A. Koutcher, W. M. Spees, B. J. Beattie, V. Ponomarev, M. Doubrovin, I. M. Buchanan, T. Beresten, K. L. Zakian, H. C. Le, et al.
Imaging Transgene Activity In vivo
Cancer Res., April 15, 2008; 68(8): 2878 - 2884.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
J. Kurhanewicz
Magnetic Resonance Imaging Biomarkers of Prostate Cancer
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 523 - 526.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
Y. Mazaheri, A. Shukla-Dave, H. Hricak, S. W. Fine, J. Zhang, G. Inurrigarro, C. S. Moskowitz, N. M. Ishill, V. E. Reuter, K. Touijer, et al.
Prostate Cancer: Identification with Combined Diffusion-weighted MR Imaging and 3D 1H MR Spectroscopic Imaging--Correlation with Pathologic Findings
Radiology, February 1, 2008; 246(2): 480 - 488.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. C. Westphalen, F. V. Coakley, A. Qayyum, M. Swanson, J. P. Simko, Y. Lu, S. Zhao, P. R. Carroll, B. M. Yeh, and J. Kurhanewicz
Peripheral Zone Prostate Cancer: Accuracy of Different Interpretative Approaches with MR and MR Spectroscopic Imaging
Radiology, December 1, 2007; 246(1): 177 - 184.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
T. W. J. Scheenen, S. W. T. P. J. Heijmink, S. A. Roell, C. A. Hulsbergen Van de Kaa, B. C. Knipscheer, J. A. Witjes, J. O. Barentsz, and A. Heerschap
Three-dimensional Proton MR Spectroscopy of Human Prostate at 3 T without Endorectal Coil: Feasibility
Radiology, November 1, 2007; 245(2): 507 - 516.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Shukla-Dave, H. Hricak, C. Moskowitz, N. Ishill, O. Akin, K. Kuroiwa, J. Spector, M. Kumar, V. E. Reuter, J. A. Koutcher, et al.
Detection of Prostate Cancer with MR Spectroscopic Imaging: An Expanded Paradigm Incorporating Polyamines
Radiology, November 1, 2007; 245(2): 499 - 506.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
M. A. Jacobs, T. S. Ibrahim, and R. Ouwerkerk
AAPM/RSNA Physics Tutorials AAPM/RSNA Physics Tutorials for Residents: MR Imaging: Brief Overview and Emerging Applications
RadioGraphics, July 1, 2007; 27(4): 1213 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. L. Speight and M. Roach III
Advances in the Treatment of Localized Prostate Cancer: The Role of Anatomic and Functional Imaging in Men Managed With Radiotherapy
J. Clin. Oncol., March 10, 2007; 25(8): 987 - 995.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
Y. J. Choi, J. K. Kim, N. Kim, K. W. Kim, E. K. Choi, and K.-S. Cho
Functional MR Imaging of Prostate Cancer
RadioGraphics, January 1, 2007; 27(1): 63 - 75.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. J. Futterer, S. W. T. P. J. Heijmink, T. W. J. Scheenen, J. Veltman, H. J. Huisman, P. Vos, C. A. H.-V. de Kaa, J. A. Witjes, P. F. M. Krabbe, A. Heerschap, et al.
Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging
Radiology, November 1, 2006; 241(2): 449 - 458.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. Wetter, T. A. Engl, D. Nadjmabadi, K. Fliessbach, T. Lehnert, J. Gurung, W.-D. Beecken, and T. J. Vogl
Combined MRI and MR spectroscopy of the prostate before radical prostatectomy.
Am. J. Roentgenol., September 1, 2006; 187(3): 724 - 730.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. A. Kwee, H. Wei, I. Sesterhenn, D. Yun, and M. N. Coel
Localization of Primary Prostate Cancer with Dual-Phase 18F-Fluorocholine PET
J. Nucl. Med., February 1, 2006; 47(2): 262 - 269.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
H Hricak
MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer
Br. J. Radiol., October 1, 2005; 78(Special_Issue_2): S103 - S111.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Prando, J. Kurhanewicz, A. P. Borges, E. M. Oliveira Jr, and E. Figueiredo
Prostatic Biopsy Directed with Endorectal MR Spectroscopic Imaging Findings in Patients with Elevated Prostate Specific Antigen Levels and Prior Negative Biopsy Findings: Early Experience
Radiology, September 1, 2005; 236(3): 903 - 910.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. Pucar, A. Shukla-Dave, H. Hricak, C. S. Moskowitz, K. Kuroiwa, S. Olgac, L. E. Ebora, P. T. Scardino, J. A. Koutcher, and K. L. Zakian
Prostate Cancer: Correlation of MR Imaging and MR Spectroscopy with Pathologic Findings after Radiation Therapy-Initial Experience
Radiology, August 1, 2005; 236(2): 545 - 553.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
H. J. Huisman, J. J. Futterer, E. N. J. T. van Lin, A. Welmers, T. W. J. Scheenen, J. A. van Dalen, A. G. Visser, J. A. Witjes, and J. O. Barentsz
Prostate Cancer: Precision of Integrating Functional MR Imaging with Radiation Therapy Treatment by Using Fiducial Gold Markers
Radiology, July 1, 2005; 236(1): 311 - 317.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
K. L. Zakian, K. Sircar, H. Hricak, H.-N. Chen, A. Shukla-Dave, S. Eberhardt, M. Muruganandham, L. Ebora, M. W. Kattan, V. E. Reuter, et al.
Correlation of Proton MR Spectroscopic Imaging with Gleason Score Based on Step-Section Pathologic Analysis after Radical Prostatectomy
Radiology, March 1, 2005; 234(3): 804 - 814.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. Beyersdorff, A. Winkel, B. Hamm, S. Lenk, S. A. Loening, and M. Taupitz
MR Imaging-guided Prostate Biopsy with a Closed MR Unit at 1.5 T: Initial Results
Radiology, February 1, 2005; 234(2): 576 - 581.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. A. Jung, F. V. Coakley, D. B. Vigneron, M. G. Swanson, A. Qayyum, V. Weinberg, K. D. Jones, P. R. Carroll, and J. Kurhanewicz
Prostate Depiction at Endorectal MR Spectroscopic Imaging: Investigation of a Standardized Evaluation System
Radiology, December 1, 2004; 233(3): 701 - 708.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
F. V. Coakley, H. S. Teh, A. Qayyum, M. G. Swanson, Y. Lu, M. Roach III, B. Pickett, K. Shinohara, D. B. Vigneron, and J. Kurhanewicz
Endorectal MR Imaging and MR Spectroscopic Imaging for Locally Recurrent Prostate Cancer after External Beam Radiation Therapy: Preliminary Experience
Radiology, November 1, 2004; 233(2): 441 - 448.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. Qayyum, F. V. Coakley, Y. Lu, J. D. Olpin, L. Wu, B. M. Yeh, P. R. Carroll, and J. Kurhanewicz
Organ-Confined Prostate Cancer: Effect of Prior Transrectal Biopsy on Endorectal MRI and MR Spectroscopic Imaging
Am. J. Roentgenol., October 1, 2004; 183(4): 1079 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
F. G. Claus, H. Hricak, and R. R. Hattery
Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and 1H MR Spectroscopy
RadioGraphics, October 1, 2004; 24(suppl_1): S167 - S180.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. E. Donnelly, B. J. Donnelly, J. C. Saliken, E. L. Raber, and A. D. Vellet
Prostate Cancer: Gadolinium-enhanced MR Imaging at 3 Weeks Compared with Needle Biopsy at 6 Months after Cryoablation
Radiology, September 1, 2004; 232(3): 830 - 833.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
C.-K. Wang, C.-W. Li, T.-J. Hsieh, S.-H. Chien, G.-C. Liu, and K.-B. Tsai
Characterization of Bone and Soft-Tissue Tumors with in Vivo 1H MR Spectroscopy: Initial Results
Radiology, August 1, 2004; 232(2): 599 - 605.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Shukla-Dave, H. Hricak, S. C. Eberhardt, S. Olgac, M. Muruganandham, P. T. Scardino, V. E. Reuter, J. A. Koutcher, and K. L. Zakian
Chronic Prostatitis: MR Imaging and 1H MR Spectroscopic Imaging Findings--Initial Observations
Radiology, June 1, 2004; 231(3): 717 - 724.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. P. Dyke, K. L. Zakian, W. M. Spees, C. Matei, Y. Chen, X. Mao, D. C. Shungu, and J. A. Koutcher
Metabolic Response of the CWR22 Prostate Tumor Xenograft after 20 Gy of Radiation Studied by 1H Spectroscopic Imaging
Clin. Cancer Res., October 1, 2003; 9(12): 4529 - 4536.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
K. L. Zakian, S. Eberhardt, H. Hricak, A. Shukla-Dave, S. Kleinman, M. Muruganandham, K. Sircar, M. W. Kattan, V. E. Reuter, P. T. Scardino, et al.
Transition Zone Prostate Cancer: Metabolic Characteristics at H MR Spectroscopic Imaging--Initial Results
Radiology, October 1, 2003; 229(1): 241 - 247.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. Swindle, S. McCredie, P. Russell, U. Himmelreich, M. Khadra, C. Lean, and C. Mountford
Pathologic Characterization of Human Prostate Tissue with Proton MR Spectroscopy
Radiology, July 1, 2003; 228(1): 144 - 151.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
A J Schwarz, N R Maisey, D J Collins, D Cunningham, R Huddart, and M O Leach
Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours
Br. J. Radiol., December 1, 2002; 75(900): 959 - 966.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. Beyersdorff, M. Taupitz, B. Winkelmann, T. Fischer, S. Lenk, S. A. Loening, and B. Hamm
Patients with a History of Elevated Prostate-Specific Antigen Levels and Negative Transrectal US-guided Quadrant or Sextant Biopsy Results: Value of MR Imaging
Radiology, September 1, 2002; 224(3): 701 - 706.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
C M Nutting, C M Corbishley, B Sanchez-Nieto, V P Cosgrove, S Webb, and D P Dearnaley
Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy
Br. J. Radiol., February 1, 2002; 75(890): 151 - 161.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
F. V. Coakley, H. Hricak, A. E. Wefer, J. L. Speight, J. Kurhanewicz, and M. R. III
Brachytherapy for Prostate Cancer: Endorectal MR Imaging of Local Treatment-related Changes
Radiology, June 1, 2001; 219(3): 817 - 821.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Ackerstaff, B. R. Pflug, J. B. Nelson, and Z. M. Bhujwalla
Detection of Increased Choline Compounds with Proton Nuclear Magnetic Resonance Spectroscopy Subsequent to Malignant Transformation of Human Prostatic Epithelial Cells
Cancer Res., May 1, 2001; 61(9): 3599 - 3603.
[Abstract] [Full Text]

Home page
 Am. J. Roentgenol.Home page
J. R. Thornbury, D. K. Ornstein, P. L. Choyke, C. P. Langlotz, and J. C. Weinreb
Prostate Cancer: What Is the Future Role for Imaging?
Am. J. Roentgenol., January 1, 2001; 176(1): 17 - 22.
[Full Text]

Home page
 RadiologyHome page
A. R. Margulis and J. H. Sunshine
Radiology at the Turn of the Millennium1
Radiology, January 1, 2000; 214(1): 15 - 23.
[Abstract] [Full Text]

Home page
 RadiologyHome page
M. van der Graaf, H. J. van den Boogert, G. J. Jager, J. O. Barentsz, and A. Heerschap
Human Prostate: Multisection Proton MR Spectroscopic Imaging with a Single Spin-Echo Sequence-Preliminary Experience
Radiology, December 1, 1999; 213(3): 919 - 925.
[Abstract] [Full Text]

Home page
 RadiologyHome page
J. Scheidler, H. Hricak, D. B. Vigneron, K. K. Yu, D. L. Sokolov, L. R. Huang, C. J. Zaloudek, S. J. Nelson, P. R. Carroll, and J. Kurhanewicz
Prostate Cancer: Localization with Three-dimensional Proton MR Spectroscopic Imaging-Clinicopathologic Study
Radiology, November 1, 1999; 213(2): 473 - 480.
[Abstract] [Full Text]

Home page
 RadiologyHome page
K. K. Yu, J. Scheidler, H. Hricak, D. B. Vigneron, C. J. Zaloudek, R. G. Males, S. J. Nelson, P. R. Carroll, and J. Kurhanewicz
Prostate Cancer: Prediction of Extracapsular Extension with Endorectal MR Imaging and Three-dimensional Proton MR Spectroscopic Imaging
Radiology, November 1, 1999; 213(2): 481 - 488.
[Abstract] [Full Text]

Home page
 RadiologyHome page
U. G. Mueller-Lisse, D. B. Vigneron, H. Hricak, M. G. Swanson, P. R. Carroll, A. Bessette, J. Scheidler, A. Srivastava, R. G. Males, I. Cha, et al.
Localized Prostate Cancer: Effect of Hormone Deprivation Therapy Measured by Using Combined Three-dimensional 1H MR Spectroscopy and MR Imaging: Clinicopathologic Case-controlled Study
Radiology, November 1, 2001; 221(2): 380 - 390.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
F. V. Coakley, J. Kurhanewicz, Y. Lu, K. D. Jones, M. G. Swanson, S. D. Chang, P. R. Carroll, and H. Hricak
Prostate Cancer Tumor Volume: Measurement with Endorectal MR and MR Spectroscopic Imaging
Radiology, April 1, 2002; 223(1): 91 - 97.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1996 by the Radiological Society of North America.